Prelude Therapeutics Incorporat (PRLD) Financials
PRLD Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 277.7 million | 40.6 million |
2023-09-30 | 258.5 million | 20.3 million |
2023-06-30 | 280.6 million | 18.6 million |
2023-03-31 | 198.3 million | 23.0 million |
PRLD Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -24.7 million | 5.9 million |
2023-09-30 | -26.3 million | 6.7 million |
2023-06-30 | -28.7 million | 6.7 million |
2023-03-31 | -30.9 million | 6.3 million |
PRLD Net Income
No data available :(
PRLD Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 232.9 million | - | 16.9 million |
2023-09-30 | 230.5 million | - | 475000 |
2023-06-30 | 255.0 million | - | 938000 |
2023-03-31 | 172.3 million | - | 1.4 million |
PRLD Shares Outstanding
PRLD Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 1.1 million | 30.3 million | 7.0 million | - |
2023-09-30 | 591000 | 26.3 million | 7.1 million | - |
2023-06-30 | 983000 | 25.0 million | 7.4 million | - |
2023-03-31 | 810000 | 21.8 million | 7.3 million | - |
PRLD Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 331000 |
2023-09-30 | - | 279000 |
2023-06-30 | - | 723000 |
2023-03-31 | - | 710000 |
PRLD
Price: $4.07
52 week price:
Earnings Per Share: -2.02 USD
P/E Ratio: -1.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 65500
Market Capitalization: 286.7 million